Key result
Glibenclamide specifically antagonized the negative inotropic effects of potassium channel openers cromakalim, pinacidil, and nicorandil in canine atrial muscle, yielding pA2 values of 6.06 to 6.35.
Glibenclamide specifically antagonizes the negative inotropic effects of potassium channel openers in canine atrial muscle, suggesting competition at the ATP-sensitive potassium channel.
Answers are grounded in this paper and cite their sources.
Glibenclamide selectively antagonizes K+ opener effects in canine atrium; leaves open translation to human cardiac electrophysiology or therapy.
The mode of antagonism by glibenclamide, a potassium channel blocker, of the negative inotropic effects of potassium channel openers, cromakalim, pinacidil and nicorandil, was investigated in canine atrial muscle. Glibenclamide shifted the concentration-negative inotropic effect curves for cromakalim, pinacidil and nicorandil to the right without affecting the basal force of contraction. Schild analysis yielded uniform pA2 values of 6.06-6.35 for glibenclamide against the three potassium channel openers. The force of contraction of atrial muscles previously reduced by cromakalim was also antagonized by increasing concentrations of glibenclamide. Glibenclamide affected neither the concentration-negative inotropic effect curves for carbachol, an opener of the muscarinic receptor-coupled potassium channel, nor those for nifedipine, a calcium channel blocker. From these results, it became evident that glibenclamide behaved as a pharmacological antagonist of cromakalim, pinacidil and nicorandil in cardiac inotropy. The antagonism seems to involve competition of glibenclamide and these potassium channel openers, presumably at the ATP-sensitive channel in canine right atrial muscles.
No takes yet. Share an insight, caveat, or question.
Satoh et al. (1990) studied Healthy canine atrial muscle. Glibenclamide vs. Control (no glibenclamide) was evaluated on Antagonism of negative inotropic effects of potassium channel openers (pA2 values) (pA2 6.06-6.35). Glibenclamide specifically antagonized the negative inotropic effects of potassium channel openers cromakalim, pinacidil, and nicorandil in canine atrial muscle, yielding pA2 values of 6.06 to 6.35.
Synapse has enriched 10 related papers. Consider them for comparative context: